Search research articles
Contact Us
Filters
Showing results (351-360 of 515) with videos related to
Page
of 52
Sort By:
Phytotherapy Research : PTR
|
February 7, 2022
Morus alba L. water extract changes gut microbiota and fecal metabolome in mice induced by high-fat and high-sucrose diet plus low-dose streptozotocin
Yan Du, Ding-Xiang Li, Dong-Yu Lu, et al.
Journal of Cancer
|
October 13, 2018
Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort
Qian Zhu, Hao Hu, Lin-Quan Tang, et al.
Journal of Translational Medicine
|
June 14, 2013
Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis
Li-na Liu, Pei-yu Huang, Zhi-rui Lin, et al.
BMC Cancer
|
August 11, 2022
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma
Shan-Shan Guo, Yan-Zhou Chen, Li-Ting Liu, et al.
Cell Reports
|
August 25, 2021
Disrupting phosphorylation of Tyr-1070 at GluN2B selectively produces resilience to depression-like behaviors
Xiaofang Shi, Qi Zhang, Jie Li, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 2, 2019
Predictive metabolic signatures for the occurrence and development of diabetic nephropathy and the intervention of Ginkgo biloba leaves extract based on gas or liquid chromatography with mass spectrometry
Yan Du, Bing-Ju Xu, Xu Deng, et al.
Aging
|
March 30, 2020
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein-Barr virus DNA level after induction chemotherapy
Sai-Lan Liu, Xue-Song Sun, Li-Ting Liu, et al.
Medicine
|
February 5, 2016
Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
Wen-Hui Chen, Lin-Quan Tang, Shan-Shan Guo, et al.
Oral Oncology
|
February 24, 2023
A new prognostic model for predicting outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma receiving subsequent line (≥2 lines) anti-programmed death-1 monotherapy
Su-Chen Li, Shen-Wen Deng, Xue-Song Sun, et al.
Frontiers in Oncology
|
March 30, 2026
A dynamic immune response index combining C-reactive protein and lactate dehydrogenase kinetics is associated with outcomes of PD-1 inhibitor monotherapy in recurrent/metastatic nasopharyngeal carcinoma
Jia-Min Chen, Su-Chen Li, Rui-Xin Liu, et al.
Page
of 52
Search research articles
Search
Showing results (351-360 of 515) with videos related to
Sort By:
Page
of 52
Phytotherapy Research : PTR
|
February 7, 2022
Morus alba L. water extract changes gut microbiota and fecal metabolome in mice induced by high-fat and high-sucrose diet plus low-dose streptozotocin
Yan Du, Ding-Xiang Li, Dong-Yu Lu, et al.
Journal of Cancer
|
October 13, 2018
Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort
Qian Zhu, Hao Hu, Lin-Quan Tang, et al.
Journal of Translational Medicine
|
June 14, 2013
Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis
Li-na Liu, Pei-yu Huang, Zhi-rui Lin, et al.
BMC Cancer
|
August 11, 2022
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma
Shan-Shan Guo, Yan-Zhou Chen, Li-Ting Liu, et al.
Cell Reports
|
August 25, 2021
Disrupting phosphorylation of Tyr-1070 at GluN2B selectively produces resilience to depression-like behaviors
Xiaofang Shi, Qi Zhang, Jie Li, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 2, 2019
Predictive metabolic signatures for the occurrence and development of diabetic nephropathy and the intervention of Ginkgo biloba leaves extract based on gas or liquid chromatography with mass spectrometry
Yan Du, Bing-Ju Xu, Xu Deng, et al.
Aging
|
March 30, 2020
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein-Barr virus DNA level after induction chemotherapy
Sai-Lan Liu, Xue-Song Sun, Li-Ting Liu, et al.
Medicine
|
February 5, 2016
Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
Wen-Hui Chen, Lin-Quan Tang, Shan-Shan Guo, et al.
Oral Oncology
|
February 24, 2023
A new prognostic model for predicting outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma receiving subsequent line (≥2 lines) anti-programmed death-1 monotherapy
Su-Chen Li, Shen-Wen Deng, Xue-Song Sun, et al.
Frontiers in Oncology
|
March 30, 2026
A dynamic immune response index combining C-reactive protein and lactate dehydrogenase kinetics is associated with outcomes of PD-1 inhibitor monotherapy in recurrent/metastatic nasopharyngeal carcinoma
Jia-Min Chen, Su-Chen Li, Rui-Xin Liu, et al.
Page
of 52